Literature DB >> 26680134

Addition of low-dose valproic acid to saline resuscitation provides neuroprotection and improves long-term outcomes in a large animal model of combined traumatic brain injury and hemorrhagic shock.

Ihab Halaweish1, Ted Bambakidis, Zhigang Chang, He Wei, Baoling Liu, Yongqing Li, Toby Bonthrone, Ashok Srinivasan, Tess Bonham, Kiril Chtraklin, Hasan B Alam.   

Abstract

BACKGROUND: Combined traumatic brain injury (TBI) and hemorrhagic shock (HS) is highly lethal. In a nonsurvival model of TBI + HS, addition of high-dose valproic acid (VPA) (300 mg/kg) to hetastarch reduced brain lesion size and associated swelling 6 hours after injury; whether this would have translated into better neurologic outcomes remains unknown. It is also unclear whether lower doses of VPA would be neuroprotective. We hypothesized that addition of low-dose VPA to normal saline (NS) resuscitation would result in improved long-term neurologic recovery and decreased brain lesion size.
METHODS: TBI was created in anesthetized swine (40-43 kg) by controlled cortical impact, and volume-controlled hemorrhage (40% volume) was induced concurrently. After 2 hours of shock, animals were randomized (n = 5 per group) to NS (3× shed blood) or NS + VPA (150 mg/kg). Six hours after resuscitation, packed red blood cells were transfused, and animals were recovered. Peripheral blood mononuclear cells were analyzed for acetylated histone-H3 at lysine-9. A Neurological Severity Score (NSS) was assessed daily for 30 days. Brain magnetic resonance imaging was performed on Days 3 and 10. Cognitive performance was assessed by training animals to retrieve food from color-coded boxes.
RESULTS: There was a significant increase in histone acetylation in the NS + VPA-treated animals compared with NS treatment. The NS + VPA group demonstrated significantly decreased neurologic impairment and faster speed of recovery as well as smaller brain lesion size compared with the NS group. Although the final cognitive function scores were similar between the groups, the VPA-treated animals reached the goal significantly faster than the NS controls.
CONCLUSION: In this long-term survival model of TBI + HS, addition of low-dose VPA to saline resuscitation resulted in attenuated neurologic impairment, faster neurologic recovery, smaller brain lesion size, and a quicker normalization of cognitive functions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26680134     DOI: 10.1097/TA.0000000000000789

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  20 in total

1.  Complete and Partial Aortic Occlusion for the Treatment of Hemorrhagic Shock in Swine.

Authors:  Aaron M Williams; Umar F Bhatti; Isabel S Dennahy; Kiril Chtraklin; Panpan Chang; Nathan J Graham; Basil M Baccouche; Shalini Roy; Mohammed Harajli; Jing Zhou; Vahagn C Nikolian; Qiufang Deng; Yuzi Tian; Baoling Liu; Yongqing Li; Gregory L Hays; Julia L Hays; Hasan B Alam
Journal:  J Vis Exp       Date:  2018-08-24       Impact factor: 1.355

2.  Valproic acid improves survival and decreases resuscitation requirements in a swine model of prolonged damage control resuscitation.

Authors:  Aaron M Williams; Umar F Bhatti; Ben E Biesterveld; Nathan J Graham; Kiril Chtraklin; Jing Zhou; Isabel S Dennahy; Ranganath G Kathawate; Claire A Vercruysse; Rachel M Russo; Yongqing Li; Hasan B Alam
Journal:  J Trauma Acute Care Surg       Date:  2019-08       Impact factor: 3.313

3.  Transcriptomic changes following valproic acid treatment promote neurogenesis and minimize secondary brain injury.

Authors:  Vahagn C Nikolian; Isabel S Dennahy; Gerald A Higgins; Aaron M Williams; Michael Weykamp; Patrick E Georgoff; Hassan Eidy; Mohamed H Ghandour; Panpan Chang; Hasan B Alam
Journal:  J Trauma Acute Care Surg       Date:  2018-03       Impact factor: 3.313

4.  Safety and Tolerability of Intravenous Valproic Acid in Healthy Subjects: A Phase I Dose-Escalation Trial.

Authors:  Patrick E Georgoff; Vahagn C Nikolian; Tess Bonham; Manjunath P Pai; Celia Tafatia; Ihab Halaweish; Kathleen To; Kuanwong Watcharotone; Aishwarya Parameswaran; Ruijuan Luo; Duxin Sun; Hasan B Alam
Journal:  Clin Pharmacokinet       Date:  2018-02       Impact factor: 6.447

5.  Lung Protective Effects of Low-Volume Resuscitation and Pharmacologic Treatment of Swine Subjected to Polytrauma and Hemorrhagic Shock.

Authors:  Vahagn C Nikolian; Baihong Pan; Tomaz Mesar; Isabel S Dennahy; Patrick E Georgoff; Xiuzhen Duan; Baoling Liu; Xizi Wu; Michael J Duggan; Hasan B Alam; Yongqing Li
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

Review 6.  Different resuscitation strategies and novel pharmacologic treatment with valproic acid in traumatic brain injury.

Authors:  Simone E Dekker; Vahagn C Nikolian; Martin Sillesen; Ted Bambakidis; Patrick Schober; Hasan B Alam
Journal:  J Neurosci Res       Date:  2017-07-25       Impact factor: 4.164

Review 7.  Histone Deacetylase Inhibitors: A Novel Strategy in Trauma and Sepsis.

Authors:  Aaron M Williams; Isabel S Dennahy; Umar F Bhatti; Ben E Biesterveld; Nathan J Graham; Yongqing Li; Hasan B Alam
Journal:  Shock       Date:  2019-09       Impact factor: 3.454

8.  Defying Death.

Authors:  Hasan B Alam
Journal:  Crit Care Med       Date:  2015-12       Impact factor: 7.598

9.  Traumatic brain injury may worsen clinical outcomes after prolonged partial resuscitative endovascular balloon occlusion of the aorta in severe hemorrhagic shock model.

Authors:  Aaron M Williams; Umar F Bhatti; Isabel S Dennahy; Nathan J Graham; Vahagn C Nikolian; Kiril Chtraklin; Panpan Chang; Jing Zhou; Ben E Biesterveld; Jonathan Eliason; Hasan B Alam
Journal:  J Trauma Acute Care Surg       Date:  2019-03       Impact factor: 3.313

10.  A systematic review of large animal models of combined traumatic brain injury and hemorrhagic shock.

Authors:  Andrew R Mayer; Andrew B Dodd; Meghan S Vermillion; David D Stephenson; Irshad H Chaudry; Denis E Bragin; Andrew P Gigliotti; Rebecca J Dodd; Benjamin C Wasserott; Priyank Shukla; Rachel Kinsler; Sheila M Alonzo
Journal:  Neurosci Biobehav Rev       Date:  2019-06-27       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.